ARKG vs MDY
ARK Genomic Revolution ETF vs SPDR S&P MidCap 400 ETF Trust
ARKG—
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: —Yield: —
MDY—
SPDR S&P MidCap 400 ETF Trust
Tracks the S&P MidCap 400 index.
Expense: —Yield: —
Side-by-side metrics
| Metric | ARKG | MDY |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | ARK | State Street |
ARKG top holdings
Holdings data unavailable for ARKG.
MDY top holdings
Holdings data unavailable for MDY.
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology.
About MDY
MDY (SPDR S&P MidCap 400 ETF Trust) is Tracks the S&P MidCap 400 index.